Immunology - Immune Responses Flashcards
(50 cards)
1
Q
Acute-phase reactants
- General
- Positive (upregulated)
- Serum amyloid A
- C-reactive protein
- Ferritin
- Fibrinogen
- Hepcidin
- Negative (downregulated)
- Albumin
- Transferrin
A
- General
- Factors whose serum concentrations change significantly in response to inflammation
- Produced by the liver in both acute and chronic inflammatory states.
- Induced by IL-6, IL-1, TNF-α, and IFN-γ.
- Positive (upregulated)
- Serum amyloid A
- Prolonged elevation can lead to amyloidosis.
- C-reactive protein
- Opsonin; fixes complement and facilitates phagocytosis.
- Measured clinically as a sign of ongoing inflammation.
- Ferritin
- Binds and sequesters iron to inhibit microbial iron scavenging.
- Fibrinogen
- Coagulation factor
- Promotes endothelial repair
- Correlates with ESR
- Hepcidin
- Prevents release of iron bound by ferritin –> anemia of chronic disease.
- Serum amyloid A
- Negative (downregulated)
- Albumin
- Reduction conserves amino acids for positive reactants.
- Transferrin
- Internalized by macrophages to sequester iron.
- Albumin
2
Q
Complement (204)
- Overview
- Activation
- Functions
- Opsonins
- Inhibitors
A
- Overview
- System of interacting plasma proteins that play a role in innate immunity and inflammation.
- MAC defends against gram-negative bacteria.
- Activation
-
Classic** pathway—Ig_G_** or IgM mediated.
- GM makes classic cars.
- Alternative pathway—microbe surface molecules.
- Lectin pathway—mannose or other sugars on microbe surface.
-
Classic** pathway—Ig_G_** or IgM mediated.
- Functions
- C3b—opsonization.
- C3b** _b_inds bacteria.**
- C3a**, C4**a**, C5**a**—**anaphylaxis.
- C5a—neutrophil chemotaxis.
- C5b-9—cytolysis by membrane attack complex (MAC).
- C3b—opsonization.
- Opsonins
- C3b and IgG are the two 1° opsonins in bacterial defense
- C3b also helps clear immune complexes.
- Inhibitors
- Decay-accelerating factor (DAF, aka CD55) and C1 esterase inhibitor help prevent complement activation on self cells (e.g., RBC).

3
Q
Complement disorders
- C1 esterase inhibitor deficiency
- C3 deficiency
- C5–C9 deficiencies
- DAF (GPI anchored enzyme) deficiency
A
- C1 esterase inhibitor deficiency
- Causes hereditary angioedema.
- ACE inhibitors are contraindicated.
- C3 deficiency
- Increases risk of severe, recurrent pyogenic sinus and respiratory tract infections
- Increases susceptibility to type III hypersensitivity reactions.
- C5–C9 deficiencies
- Increase susceptibility to recurrent Neisseria bacteremia.
- DAF (GPI anchored enzyme) deficiency
- Causes complement-mediated lysis of RBCs and paroxysmal nocturnal hemoglobinuria.
4
Q
Important cytokines:
L 1-6 (mnemonic)
A
- “Hot T-bone stEAK”
- IL-1: fever (hot).
- IL-2: stimulates T cells.
- IL-3: stimulates bone marrow.
- IL-4: stimulates IgE production.
- IL-5: stimulates IgA production.
- IL-6: stimulates aKute-phase protein production.
5
Q
IL-1
A
- Secreted by macrophages
- An endogenous pyrogen, also called osteoclast-activating factor.
- Causes fever, acute inflammation.
- Activates endothelium to express adhesion molecules
- Induces chemokine secretion to recruit leukocytes.
6
Q
IL-6
A
- Secreted by macrophages
- An endogenous pyrogen.
- Also secreted by Th2 cells.
- Causes fever and stimulates production of acute-phase proteins.
7
Q
IL-8
A
- Secreted by macrophages
- Major chemotactic factor for neutrophils.
- Neutrophils are recruited by IL-8 to clear infections.
- “Clean up on aisle 8.”
8
Q
IL-12
A
- Secreted by macrophages
- Induces differentiation of T cells into Th1 cells.
- Activates NK cells.
- Also secreted by B cells.
9
Q
TNF-a
A
- Secreted by macrophages
- Mediates septic shock.
- Activates endothelium.
- Causes leukocyte recruitment, vascular leak.
10
Q
IL-2
A
- Secreted by all T cells
- Stimulates growth of helper, cytotoxic, and regulatory T cells.
11
Q
IL-3
A
- Secreted by all T cells
- Supports the growth and differentiation of bone marrow stem cells.
- Functions like GM-CSF.
12
Q
Interferon-γ
A
- From Th1 cells
- Has antiviral and antitumor properties.
- Activates NK cells to kill virus-infected cells
- Increases MHC expression and antigen presentation in all cells.
13
Q
IL-4
A
- From Th2 cells
- Induces differentiation into Th2 cells.
- Promotes growth of B cells.
- Enhances class switching to IgE and IgG.
14
Q
IL-5
A
- From Th2 cells
- Promotes differentiation of B cells.
- Enhances class switching to IgA.
- Stimulates the growth and differentiation of eosinophils.
15
Q
IL-10
A
- From Th2 cells
- Modulates inflammatory response.
- Inhibits actions of activated T cells and Th1.
- Also secreted by regulatory T cells.
- TGF-β has similar actions to IL-10, because it is involved in inhibiting inflammation.
16
Q
Interferon α and β
A
- A part of innate host defense against both RNA and DNA viruses.
-
Interferons are glycoproteins synthesized by viral-infected cells that act locally on uninfected cells, “priming them” for viral defense.
- Interferes with viruses.
- When a virus infects “primed” cells, viral dsRNA activates:
- RNAase L –> degradation of viral/host mRNA.
- Protein kinase –> inhibition of viral/host protein synthesis.
- Essentially results in apoptosis, thereby interrupting viral amplification.
17
Q
Cell surface proteins
- All except mature RBCs have…
- T cells
- Helper T cells
- Cytotoxic T cells
- B cells
- Macrophages
- NK cells
A
- All cells except mature RBCs have MHC I.
- T cells
- TCR (binds antigen-MHC complex)
- CD3 (associated with TCR for signal transduction)
- CD28 (binds B7 on APC)
- Helper T cells
- CD4, CD40 ligand
- Cytotoxic T cells
- CD8
- B cells
- Ig (binds antigen)
- CD19, CD20, CD21 (receptor for EBV), CD40
- MHC II, B7
-
You can drink Beer at the Bar when you’re 21
- __B cells, Epstein-Barr virus; CD-_21_.
- Macrophages
- CD14, CD40
- MHC II, B7
- Fc and C3b receptors (enhanced phagocytosis)
- NK cells
- CD16 (binds Fc of IgG)
- CD56 (unique marker for NK)
18
Q
Anergy
A
- Self-reactive T cells become nonreactive without costimulatory molecule.
- B cells also become anergic, but tolerance is less complete than in T cells.
19
Q
Effects of bacterial toxins
- Superantigens
- Endotoxins/lipopolysaccharide
A
- Superantigens (S. pyogenes and S. aureus)
- Cross-link the β region of the T-cell receptor to the MHC class II on APCs.
- Can activate any T cell, leading to massive release of cytokines.
- Endotoxins/lipopolysaccharide (gram-negative bacteria)
- Directly stimulate macrophages by binding to endotoxin receptor CD14
- Th cells are not involved.
20
Q
Antigenic variation
- Classic examples
- Bacteria
- Virus
- Parasites
- Some mechanisms for variation
A
- Classic examples:
- Bacteria
- Salmonella (2 flagellar variants)
- Borrelia (relapsing fever)
- Neisseria gonorrhoeae (pilus protein).
- Virus
- Influenza (major = shift, minor = drift).
- Parasites
- Trypanosomes (programmed rearrangement).
- Bacteria
- Some mechanisms for variation
- DNA rearrangement
- RNA segment reassortment (e.g., influenza major shift).
21
Q
Passive vs. active immunity
- Means of acquisition
- Onset
- Duration
- Examples
- Notes
A
- Means of acquisition
- P: Receiving preformed antibodies
- A: Exposure to foreign antigens
- Onset
- P: Rapid
- A: Slow
- Duration
- P: Short span of antibodies (half-life = 3 weeks)
- A: Long-lasting protection (memory)
- Examples
- P: IgA in breast milk, maternal IgG crossing placenta, antitoxin, humanized monoclonal antibody
- A: Natural infection, vaccines, toxoid
- Notes
-
P: After exposure to Tetanus toxin, Botulinum toxin, HBV, or Rabies virus, patients are given preformed antibodies (passive)
- “To Be Healed Rapidly”
- A: Combined passive and active immunizations can be given for hepatitis B or rabies exposure
-
P: After exposure to Tetanus toxin, Botulinum toxin, HBV, or Rabies virus, patients are given preformed antibodies (passive)
22
Q
Vaccination
- Vaccines
- Live attenuated vaccine vs. Inactivated or killed vaccine
- Description
- Pros
- Cons
- Examples
A
- Vaccines
- Used to induce an active immune response (humoral and/or cellular) to specific pathogens.
- Live attenuated vaccine vs. inactivated or killed vaccine
- Description
-
L: Microorganism loses its pathogenicity but retains capacity for transient growth within inoculated host.
- Mainly induces a cellular response.
-
I/K: Pathogen is inactivated by heat or chemicals
- Maintaining epitope structure on surface antigens is important for immune response.
- Humoral immunity induced.
-
L: Microorganism loses its pathogenicity but retains capacity for transient growth within inoculated host.
- Pros
- L: Induces strong, often lifelong immunity.
- I/K: Stable and safer than live vaccines.
- Cons
-
L: May revert to virulent form.
- Often contraindicated in pregnancy and immune deficiency.
-
I/K: Weaker immune response
- Booster shots usually required.
-
L: May revert to virulent form.
- Examples
- L: Measles, mumps, rubella, polio (Sabin), influenza (intranasal), varicella, yellow fever.
- I/K: Cholera, hepatitis A, polio (Salk), influenza (injection), rabies.
- Description
23
Q
Type I hypersensitivity
- Reaction
- Types I, II, and III
- Test
A
- Reaction
- Anaphylactic and atopic—free antigen crosslinks IgE on presensitized mast cells and basophils, triggering immediate release of vasoactive amines that act at postcapillary venules (i.e., histamine).
- Reaction develops rapidly after antigen exposure because of preformed antibody.
- Delayed response follows due to production of arachidonic acid metabolites (e.g., leukotrienes).
- First (type) and Fast (anaphylaxis).
- Types I, II, and III
- All antibody mediated.
- Test
- Skin test for specific IgE.

24
Q
Type II hypersensitivity
- Reaction
- Mechanisms
- Test
A
- Reaction
- Cytotoxic (antibody mediated)
- IgM, IgG bind to fixed antigen on “enemy” cell, leading to cellular destruction.
- Antibody and complement lead to membrane attack complex (MAC).
- Type II is cy-_2_-toxic.
- 3 mechanisms:
- Opsonization leading to phagocytosis or complement activation
- Complement-mediated lysis
- Antibody-dependent cell-mediated cytotoxicity, usually due to NK cells or macrophages
- Test
- Direct Coombs’: detects antibodies that have adhered to patient’s RBCs (e.g., test an Rh (+) infant of an Rh (-) mother).
- Indirect Coombs’: detects antibodies that can adhere to other RBCs (e.g., test an Rh (-) woman for Rh (+) antibodies).

25
Type III hypersensitivity
* Reaction
* Serum sickness
* Arthus reaction
* Test
* Immune complex
* Antigen-antibody (IgG) complexes activate complement, which attracts neutrophils
* Neutrophils release lysosomal enzymes.
* **In type _III_ reaction, imagine an immune complex as _3_ things stuck together: antigen-antibody-complement.**
* **Serum sickness**
* An immune complex disease (type III) in which antibodies to the foreign proteins are produced (takes 5 days).
* Immune complexes form and are deposited in membranes, where they fix complement (leads to tissue damage).
* More common than Arthus reaction.
* Most serum sickness is now caused by drugs (not serum) acting as haptens.
* Fever, urticaria, arthralgias, proteinuria, lymphadenopathy 5–10 days after antigen exposure.
* **Arthus reaction**
* A local subacute antibody-mediated hypersensitivity (type III) reaction.
* Intradermal injection of antigen induces antibodies, which form antigen-antibody complexes in the skin.
* Characterized by edema, necrosis, and activation of complement.
* Antigen-antibody complexes cause the Arthus reaction.
* Test
* Immunofluorescent staining.

26
Type IV hypersensitivity
* Reaction
* Test
* Mnemonic
* Delayed (T-cell-mediated) type
* Sensitized T lymphocytes encounter antigen and then release lymphokines
* Leads to macrophage activation
* No antibody involved
* Cell mediated
* Therefore, it is not transferable by serum.
* **_4th_ and _last_—delayed.**
* Test
* Patch test, PPD.
* **_4_ _T_’s**
* **_T_** lymphocytes
* **_T_**ransplant rejections
* **_T_**B skin tests
* **_T_**ouching (contact dermatitis).

27
Hypersensitivity types (mnemomnic)
* **_ACID_**
* **_A_**naphylactic and **_A_**topic (_type I_)
* **_C_**ytotoxic (antibody mediated) (_type II_)
* **_I_**mmune complex (_type III_)
* **_D_**elayed (cell mediated) (_type IV_)
28
Hypersensitivity disorders
* For each
* Examples
* Presentation
* Type I
* Type II
* Type III
* Type IV
* Type I
* Examples
* Anaphylaxis (e.g., bee sting, some food/drug allergies)
* Allergic and atopic disorders (e.g., rhinitis, hay fever, eczema, hives, asthma)
* Presentation
* Immediate, anaphylactic, atopic
* Type II
* Examples
* Autoimmune hemolytic anemia
* Pernicious anemia
* Idiopathic thrombocytopenic purpura
* Erythroblastosis fetalis
* Acute hemolytic transfusion reactions
* Rheumatic fever
* Goodpasture syndrome
* Bullous pemphigoid
* Pemphigus vulgar
* Presentation
* Disease tends to be specific to tissue or site where antigen is found
* Type III
* Examples
* SLE
* Polyarteritis nodosa
* Poststreptococcal glomerulonephritis
* Serum sickness
* Arthus reaction (e.g., swelling and inflammation following tetanus vaccine)
* Presentation
* Can be associated with vasculitis and systemic manifestations
* Type IV
* Examples
* Multiple sclerosis
* Guillain-Barré syndrome
* Graft-versus-host disease
* PPD (test for M. tuberculosis)
* Contact dermatitis (e.g., poison ivy, nickel allergy)
* Presentation
* Response is delayed and does not involve antibodies (vs. types I, II, and III)
29
Blood transfusion reactions
* For each
* Pathogenesis
* Clinical presentation
* Allergic reaction
* Anaphylactic reaction
* Febrile nonhemolytic transfusion reaction
* Acute hemolytic transfusion reaction
* Allergic reaction
* _P_: Type I hypersensitivity reaction against plasma
proteins in transfused blood.
* _C_: Urticaria, pruritus, wheezing, fever.
* Treat with antihistamines.
* Anaphylactic reaction
* _P_: Severe allergic reaction.
* IgA-deficient individuals must receive blood products that lack IgA.
* _C_: Dyspnea, bronchospasm, hypotension, respiratory arrest, shock.
* Febrile nonhemolytic transfusion reaction
* _P_: Type II hypersensitivity reaction.
* Host antibodies against donor HLA antigens and leukocytes.
* _C_: Fever, headaches, chills, flushing.
* Acute hemolytic transfusion reaction
* _P_: Type II hypersensitivity reaction.
* Intravascular hemolysis (ABO blood group incompatibility) or extravascular hemolysis (host antibody reaction against foreign antigen on donor RBCs).
* _C_: Fever, hypotension, tachypnea, tachycardia, flank pain, hemoglobinemia (intravascular), jaundice (extravascular hemolysis).
30
Associated disorders of these autoantibodies
* Anti-ACh receptor
* Anti-basement membrane
* Anti-cardiolipin, lupus anticoagulant
* Anticentromere
* Anti-desmoglein
* Anti-dsDNA, anti-Smith
* Anti-glutamate decarboxylase
* Anti-hemidesmosome
* Antihistone
* Anti-Jo-1, anti-SRP, anti-Mi-2
* Antimicrosomal, antithyroglobulin
* Antimitochondrial
* Antinuclear antibodies
* Anti-Scl-70 (anti-DNA topoisomerase I)
* Anti-smooth muscle
* Anti-SSA, anti-SSB (anti-Ro, anti-La)
* Anti-TSH receptor
* Anti-U1 RNP (ribonucleoprotein)
* c-ANCA (PR3-ANCA)
* IgA antiendomysial, IgA anti-tissue transglutaminase
* p-ANCA (MPO-ANCA)
* Rheumatoid factor (antibody, most commonly IgM, specific to IgG Fc region), anti-CCP
* Anti-ACh receptor
* Myasthenia gravis
* Anti-basement membrane
* Goodpasture syndrome
* Anti-cardiolipin, lupus anticoagulant
* SLE, antiphospholipid syndrome
* Anticentromere
* Limited scleroderma (CREST syndrome)
* Anti-desmoglein
* Pemphigus vulgaris
* Anti-dsDNA, anti-Smith
* SLE
* Anti-glutamate decarboxylase
* Type 1 diabetes mellitus
* Anti-hemidesmosome
* Bullous pemphigoid
* Antihistone
* Drug-induced lupus
* Anti-Jo-1, anti-SRP, anti-Mi-2
* Polymyositis, dermatomyositis
* Antimicrosomal, antithyroglobulin
* Hashimoto thyroiditis
* Antimitochondrial
* 1° biliary cirrhosis
* Antinuclear antibodies
* SLE, nonspecific
* Anti-Scl-70 (anti-DNA topoisomerase I)
* Scleroderma (diffuse)
* Anti-smooth muscle
* Autoimmune hepatitis
* Anti-SSA, anti-SSB (anti-Ro, anti-La)
* Sjögren syndrome
* Anti-TSH receptor
* Graves disease
* Anti-U1 RNP (ribonucleoprotein)
* Mixed connective tissue disease
* c-ANCA (PR3-ANCA)
* Granulomatosis with polyangiitis (Wegener)
* IgA antiendomysial, IgA anti-tissue transglutaminase
* Celiac disease
* p-ANCA (MPO-ANCA)
* Microscopic polyangiitis, Churg-Strauss syndrome
* Rheumatoid factor (antibody, most commonly IgM, specific to IgG Fc region), anti-CCP
* Rheumatoid arthritis
31
Infections in immunodeficiency
* B-cell vs. T-cell deficiencies
* Bacteria
* No T cells
* No B cells
* No granulocyte
* No complement
* Virus
* No T cells
* No B cells
* Fungi/parasites
* No T cells
* No B cells
* No granulocyte
* B-cell vs. T-cell deficiencies
* B-cell deficiencies tend to produce recurrent bacterial infections
* T-cell deficiencies produce more fungal and viral infections.
* Bacteria
* _No T cells_: Sepsis
* _No B cells_: Encapsulated (**_SHiNE_ _SK**_i_**S_**)
* **_S_**treptococcus pneumoniae
* **_H_**aemophilus **_i_**nfluenzae type B
* **_N_**eisseria meningitidis
* **_E_**scherichia coli
* **_S_**almonella
* **_K_**lebsiella pneumoniae
* Group B **_S_**trep
* _No granulocyte_: Staphylococcus, Burkholderia cepacia, Serratia, Nocardia
* _No complement_: Neisseria (no membrane attack complex)
* Virus
* _No T cells_: CMV, EBV, JCV, VZV chronic infection with respiratory/GI viruses
* _No B cells_: Enteroviral encephalitis, poliovirus (live vaccine contraindicated)
* Fungi/parasites
* _No T cells_: Candida, PCP
* _No B cells_: GI giardiasis (no IgA)
* _No granulocyte_: Candida, Aspergillus
32
X-linked (Bruton) agammaglobulinemia
* Type of disorder
* Defect
* Presentation
* Findings
* Type of disorder
* B-cell disorder
* Defect
* Defect in **_B_**TK, a tyrosine kinase gene --\> no **_B_** cell maturation.
* X-linked recessive (increase in **_B_**oys).
* Presentation
* Recurrent bacterial and enteroviral infections after 6 months (decrease maternal IgG).
* Findings
* Normal CD19+ B cell count, decreased pro-B, decreased Ig of all classes.
* Absent/scanty lymph nodes and tonsils.
33
Selective IgA deficiency
* Type of disorder
* Defect
* Presentation
* Findings
* Type of disorder
* B-cell disorder
* Defect
* Unknown.
* Most common 1° immunodeficiency.
* Presentation
* Majority **_A_**symptomatic.
* Can see **_A_**irway and GI infections, **_A_**utoimmune disease, **_A_**topy, **_A_**naphylaxis to Ig**_A_**-containing products.
* Findings
* IgA \< 7 mg/dL with normal IgG, IgM levels.
34
Common variable immunodeficiency
* Type of disorder
* Defect
* Presentation
* Findings
* Type of disorder
* B-cell disorder
* Defect
* Defect in B-cell differentiation.
* Many causes.
* Presentation
* Can be acquired in 20s–30s
* Increased risk of autoimmune disease, bronchiectasis, lymphoma, sinopulmonary infections.
* Findings
* Decreased plasma cells
* Decreased immunoglobulins.
35
Thymic aplasia (DiGeorge syndrome)
* Type of disorder
* Defect
* Presentation
* Findings
* Type of disorder
* T-cell disorder
* Defect
* 22q11 deletion
* Failure to develop 3rd and 4th pharyngeal pouches --\> absent thymus and parathyroids.
* Presentation
* Tetany (hypocalcemia), recurrent viral/fungal infections (T-cell deficiency), conotruncal abnormalities (e.g., tetralogy of Fallot, truncus arteriosus).
* Findings
* Decreased T cells, decreased PTH, decreased Ca2+.
* Absent thymic shadow on CXR.
* 22q11 deletion detected by FISH.
36
IL-12 receptor deficiency
* Type of disorder
* Defect
* Presentation
* Findings
* Type of disorder
* T-cell disorder
* Defect
* Decreased Th1 response.
* Autosomal recessive.
* Presentation
* Disseminated mycobacterial and fungal infections
* May present after administration of BCG vaccine.
* Findings
* Decreased IFN-γ.
37
Autosomal dominant hyper-IgE syndrome (Job syndrome)
* Type of disorder
* Defect
* Presentation
* Findings
* Type of disorder
* T-cell disorder
* Defect
* Deficiency of Th17 cells due to STAT3 mutation --\> impaired recruitment of neutrophils to sites of infection.
* Presentation
* **_FATED_**: coarse **_F_**acies, cold (noninflamed) staphylococcal **_A_**bscesses, retained primary **_T_**eeth, increased Ig**_E_**, **_D_**ermatologic problems (eczema).
* Findings
* Increased IgE, decreased IFN-γ.
38
Chronic mucocutaneous candidiasis
* Type of disorder
* Defect
* Presentation
* Findings
* Type of disorder
* T-cell disorder
* Defect
* T-cell dysfunction.
* Many causes.
* Presentation
* Noninvasive Candida albicans infections of skin and mucous membranes.
* Findings
* Absent in vitro T-cell proliferation in response to Candida antigens.
* Absent cutaneous reaction to Candida antigens.
39
Severe combined immunodeficiency (SCID)
* Type of disorder
* Defect
* Presentation
* Findings
* Type of disorder
* B- and T-cell disorder
* Defect
* Several types including defective IL-2R gamma chain (most common, X-linked), adenosine deaminase deficiency (autosomal recessive).
* Presentation
* Failure to thrive, chronic diarrhea, thrush.
* Recurrent viral, bacterial, fungal, and protozoal infections.
* Treatment: bone marrow transplant (no concern for rejection).
* Findings
* Decreased T-cell receptor excision circles (TRECs).
* Absence of thymic shadow (CXR), germinal centers (lymph node biopsy), and T cells (flow cytometry).
40
Ataxia-telangiectasia
* Type of disorder
* Defect
* Presentation
* Findings
* Type of disorder
* B- and T-cell disorder
* Defect
* Defects in ATM gene --\> DNA double strand breaks --\> cell cycle arrest.
* Presentation
* Triad: cerebellar defects (**_A_**taxia), spider **_A_**ngiomas (telangiectasia), Ig**_A_** deficiency.
* Findings
* Increased AFP.
* Decreased IgA, IgG, and IgE.
* Lymphopenia, cerebellar atrophy.
41
Hyper-IgM syndrome
* Type of disorder
* Defect
* Presentation
* Findings
* Type of disorder
* B- and T-cell disorder
* Defect
* Most commonly due to defective CD40L on Th cells = class switching defect
* X-linked recessive.
* Presentation
* Severe pyogenic infections early in life
* Opportunistic infection with Pneumocystis, Cryptosporidium, CMV.
* Findings
* Increased IgM.
* Decreased IgG, IgA, IgE.
42
Wiskott-Aldrich syndrome
* Type of disorder
* Defect
* Presentation
* Findings
* Type of disorder
* B- and T-cell disorder
* Defect
* Mutation in WAS gene (X-linked recessive)
* T cells unable to reorganize actin cytoskeleton.
* Presentation
* **_WATER_**: **_W_**iskott-**_A_**ldrich: **_T_**hrombocytopenic purpura, **_E_**czema, **_R_**ecurrent infections.
* Increased risk of autoimmune disease and malignancy.
* Findings
* Decreased to normal IgG, IgM.
* Increased IgE, IgA.
* Fewer and smaller platelets.
43
Leukocyte adhesion deficiency (type 1)
* Type of disorder
* Defect
* Presentation
* Findings
* Type of disorder
* Phagocyte dysfunction
* Defect
* Defect in LFA-1 integrin (CD18) protein on phagocytes
* Impaired migration and chemotaxis
* Autosomal recessive.
* Presentation
* Recurrent bacterial skin and mucosal infections, absent pus formation, impaired wound healing, delayed separation of umbilical cord (\>30 days).
* Findings
* Increased neutrophils.
* Absence of neutrophils at infection sites.
44
Chédiak-Higashi syndrome
* Type of disorder
* Defect
* Presentation
* Findings
* Type of disorder
* Phagocyte dysfunction
* Defect
* Defect in lysosomal trafficking regulator gene (LYST).
* Microtubule dysfunction in phagosome-lysosome fusion
* Autosomal recessive.
* Presentation
* Recurrent pyogenic infections by staphylococci and streptococci, partial albinism, peripheral neuropathy, progressive neurodegeneration, infiltrative lymphohistiocytosis.
* Findings
* Giant granules in neutrophils and platelets.
* Pancytopenia.
* Mild coagulation defects.
45
Chronic granulomatous disease
* Type of disorder
* Defect
* Presentation
* Findings
* Type of disorder
* Phagocyte dysfunction
* Defect
* Defect of NADPH oxidase --\> decreased reactive oxygen species (e.g., superoxide) and absent respiratory burst in neutrophils
* X-linked recessive.
* Presentation
* Increased susceptibility to catalase (+) organisms (**_PLACESS_**): **_P_**seudomonas, **_L_**isteria, **_A_**spergillus, **_C_**andida, **_E_**. coli, **_S_**. aureus, **_S_**erratia.
* Findings
* Abnormal dihydrorhodamine (flow cytometry) test.
* Nitroblue tetrazolium dye reduction test is (-) (test out of favor).
46
Grafts
* Autograft
* Syngeneic graft
* Allograft
* Xenograft
* Autograft
* From self.
* Syngeneic graft
* From identical twin or clone.
* Allograft
* From nonidentical individual of same species.
* Xenograft
* From different species.
47
Hyperacute transplant rejection
* Onset
* Pathogenesis
* Features
* Onset
* Within minutes
* Pathogenesis
* Pre-existing recipient antibodies react to donor antigen (type II reaction), activate complement.
* Features
* Widespread thrombosis of graft vessels --\> ischemia/necrosis.
* Graft must be removed.
48
Acute transplant rejection
* Onset
* Pathogenesis
* Features
* Onset
* Weeks to months
* Pathogenesis
* Cellular: CTLs activated against donor MHCs.
* Humoral: similar to hyperacute, except antibodies develop after transplant.
* Features
* Vasculitis of graft vessels with dense interstitial lymphocytic infiltrate.
* Prevent/reverse with immunosuppressants.
49
Chronic transplant rejection
* Onset
* Pathogenesis
* Features
* Onset
* Months to years
* Pathogenesis
* Recipient T cells perceive donor MHC as recipient MHC and react against donor antigens presented.
* Both cellular and humoral components.
* Features
* Irreversible.
* T-cell and antibody-mediated damage.
* Organ specific:
* Heart—atherosclerosis.
* Lungs—bronchiolitis obliterans.
* Liver—vanishing bile ducts.
* Kidney—vascular fibrosis, glomerulopathy.
50
Graft-versus-host disease (transplant rejection)
* Onset
* Pathogenesis
* Features
* Onset
* Varies
* Pathogenesis
* Grafted immunocompetent T cells proliferate in the immunocompromised host and reject host cells with “foreign” proteins --\> severe organ dysfunction.
* Features
* Maculopapular rash, jaundice, diarrhea, hepatosplenomegaly.
* Usually in bone marrow and liver transplants (rich in lymphocytes).
* Potentially beneficial in bone marrow transplant for leukemia (graft-versus-tumor effect).